Molecular forms of human brain natriuretic peptide in plasma.
about
Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failureNesiritide in acute decompensated heart failure: current status and future perspectivesPlasma soluble corin in patients with heart failure.Secretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure.Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failureProtease corin expression and activity in failing hearts.Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.Membrane guanylyl cyclase receptors: an updateNovel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide.Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes.The cyclic guanosine monophosphate/B-type natriuretic peptide ratio and mortality in advanced heart failureA review on B-type natriuretic peptide monitoring: assays and biosensorsB-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides.Biochemistry of B-type natriuretic peptide--where are we now?Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside.Natriuretic peptides in the diagnosis and management of chronic heart failure.Molecular forms of natriuretic peptides in heart failure and their implications.B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications.Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.MS-based approaches to unravel the molecular complexity of proprotein-derived biomarkers and support their quantification: the examples of B-type natriuretic peptide and apelin peptides.Review on natriuretic peptides: where we are, where we are going.Natriuretic peptide-guided therapy: further research required for still-unresolved issues.State of the art of immunoassay methods for B-type natriuretic peptides: An update.BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 1--Cardiac diseases and pulmonary hypertension.Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency.Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity.Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure.Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.N-terminal pro-B-type natriuretic peptide and ventricular dysfunction in children and adolescents.Effect of heart failure on dipeptidyl peptidase IV activity in plasma of dogs.Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure
P2860
Q26829634-23CC80CA-5535-44CF-9EBC-BA95D2FDB916Q33878162-EEFB764E-9157-4D9B-8FBF-CF3BD71AC757Q33887635-CE2AA169-45D4-4370-BAD4-708C3561C77AQ33994980-C638BF2A-7925-47FC-AF32-C26AD0DE2B2EQ34161199-511C1D3D-FDD1-4C0E-967F-72460E9CCAA9Q34357746-5E6992D6-4F16-4A69-9E62-246B27C3761FQ36350919-AB571DF3-6C63-4B3C-963F-8E8E15B74354Q36525043-1F034F33-8237-4AD3-9388-88CD94F7FAE9Q36564032-93D4EA37-897F-4192-ACAE-952358D3B770Q36790719-40274F9A-FC6A-4A6F-A968-1FF85DD8FDDAQ37091016-E23B97CD-1111-4508-8CD0-3B9E526A5660Q37171880-A2585407-9643-487B-A2F1-EF351BA889FFQ37217952-BFCCF16B-694A-472A-913F-D0ACFFD4E40CQ37229555-1CE46182-8ACF-4229-AE8A-4DA36C3EE7B1Q37251037-94061C7A-D06C-4317-ADA6-BFDD38E4FEFBQ37289418-9FC670D8-D18C-4147-AD55-F1FD23A47EBDQ37425253-BF4BEF49-845A-4A34-BA71-64207F33FF6FQ37447544-27D8594D-32EE-40E4-B3A8-F5624282AC3CQ37487209-574D43B8-D8E8-4F62-800A-CB9DFFAD3D16Q37734430-47310B83-7BE2-44B1-AD33-666453E895A5Q37873230-9B4048A9-7E30-4CF6-8968-11CB3CD6E443Q38065253-2A3B6F2F-78A6-4223-90A4-192ACCD4FE48Q38089931-AD5ADD5A-92C8-49CF-8009-0ED97C8BD7F2Q38099221-899DFC2D-F6B5-4719-BC1E-B1BBBA2BF2F8Q38303192-D914E371-5C62-4EE6-818D-99C08AB495E1Q38324210-3265D39C-DAF5-4AEA-AFE4-C272EE52B09CQ38514901-8023C3A9-B45F-4E54-A4E1-ADE1230A70BAQ38837698-094CED14-C79F-4E9A-B1EC-DF63431059A0Q39721683-8D8A13B2-CDFC-4E01-B45D-034DB76E3FCBQ40954684-374DC611-C8BC-4CC9-8714-6ED3205A1585Q48090634-B16A9FA0-EA4E-4FB8-8624-05FDC0E69F7BQ48242668-A5FD41C7-528C-47ED-B497-CE63565AB353Q48386405-96CDC07D-6A97-429D-A091-80C4893D7A55Q48427158-9F9ECEBF-FA2B-4696-AF15-940122E37D68Q49179704-426558AA-3C0E-44A0-9558-736C27CC8110Q57097937-8D0A48FB-9A21-43EB-9B39-759BB8C955BA
P2860
Molecular forms of human brain natriuretic peptide in plasma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular forms of human brain natriuretic peptide in plasma.
@ast
Molecular forms of human brain natriuretic peptide in plasma.
@en
Molecular forms of human brain natriuretic peptide in plasma.
@nl
type
label
Molecular forms of human brain natriuretic peptide in plasma.
@ast
Molecular forms of human brain natriuretic peptide in plasma.
@en
Molecular forms of human brain natriuretic peptide in plasma.
@nl
prefLabel
Molecular forms of human brain natriuretic peptide in plasma.
@ast
Molecular forms of human brain natriuretic peptide in plasma.
@en
Molecular forms of human brain natriuretic peptide in plasma.
@nl
P2093
P1433
P1476
Molecular forms of human brain natriuretic peptide in plasma.
@en
P2093
Hidehisa Asada
Hiroyuki Shimizu
Kazuo Yamada
Kazuyoshi Aono
Kazuyuki Sasakura
Keiichi Masuta
Kenji Sugita
Mikio Tamaki
P304
P356
10.1016/S0009-8981(01)00745-8
P577
2002-02-01T00:00:00Z